An Act providing for insurance coverage for vaginal estrogen for the treatment of menopausal symptoms and urinary tract infections.
This Pennsylvania bill requires most health insurance plans to cover vaginal estrogen when used to treat menopausal symptoms or prevent urinary tract infections. The law mandates that insurers include FDA-approved drugs, devices, and combination products for this treatment, though they may still apply standard rules regarding medical necessity and patient cost-sharing. Coverage applies to new or renewed policies starting 90 days after the bill takes effect, with specific timelines for plans that do not need to file rates or forms with the state.
Bill status
in committee
3 of 5 stages cleared
Introduction
May 2026
Committee Review
Jun 2026
House Passage
Jun 2026
Senate Passage
Governor
Introduced May 27, 2026
Last action Jun 24, 2026
Floor votes · House Jun 24, 2026
How they voted
26–0
Passed
Total votes 26
Jun 24, 2026
D
Democratic14
100% Yea
R
Republican12
100% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
4
Key actions
2
Committee
3
Jun 24, 2026
House · Passed
House Vote: pass (26-0)
house
Jun 24, 2026
Committee
Re-referred to Aging & Older Adult Services
lower
Jun 24, 2026
Lower · Passed
Reported with request to re-refer to Aging & Older Adult Services
lower
May 27, 2026
Committee
Referred to Insurance
lower
1 primary · 4 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 2545
Scope: PA
Hi! I can help you understand HB 2545. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline